Throughout the 24-week study period, three patients (P1, P2, and P5) showed a decreasing trend in pain intensity based on the VAS.
← all excerpts
Intradiscal injection of allogeneic bone marrow derived clonal mesenchymal stromal cells in discogenic low back pain: a phase I study on safety and feasibility (RELIEF: phase I).
1
—
—